Five-year experience with percutaneous closure of patent foramen ovale

被引:100
作者
Slavin, Leo
Tobis, Jonathan M. [1 ]
Rangarajan, Krishnan
Dao, Catherine
Krivokapich, Janine
Liebeskind, David S.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/j.amjcard.2006.12.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patent foramen ovale (PFO) has been implicated in the pathogenesis of cryptogenic stroke, arterial desaturation, decompression illness, and migraine headache (MH). This study evaluated the safety of percutaneous transcatheter PFO closure in patients with cryptogenic stroke, transient ischemic attack, or arterial desaturation. Additionally, symptomatic reduction in MH was determined after interatrial shunt closure. Of the 252 patients referred to the University of California, Los Angeles, with PFO, 131 underwent closure of the interatrial communication with a CardioSEAL (n = 30) or Amplatzer (n = 101) device. PFO morphology was evaluated with transesophageal echocardiography. Follow-up was conducted at 1 to 2 months with echocardiography, with clinical assessment annually thereafter. At an average follow-up of 30 months, there was no recurrence of any thromboembolic event (transient ischemic attack, stroke, or peripheral). There was a reduction in MH, defined as the complete resolution of headache or a > 50% reduction in the number of headache days, in 85% of patients after PFO closure. Temporary problems after device implantation, including chest discomfort and palpitations, were reported in 23% of patients and occurred more frequently in patients with nickel hypersensitivity (p <0.05). In conclusion, transcatheter PFO closure is an effective and safe therapeutic modality in the prevention of thromboembolic events and MH associated with interatrial shunting in patients who present with cryptogenic stroke. Pending randomized, controlled trials are necessary to determine if this invasive approach is preferable to medical therapy for the prevention of recurrent stroke or as primary treatment for patients with MH. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1316 / 1320
页数:5
相关论文
共 31 条
[21]   Outcome of patients with cryptogenic stroke and patent foramen ovale [J].
Nedeltchev, K ;
Arnold, M ;
Wahl, A ;
Sturzenegger, M ;
Vella, EE ;
Windecker, S ;
Meier, B ;
Mattle, HP .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (03) :347-350
[22]  
Onorato Eustaquio, 2003, J Interv Cardiol, V16, P43
[23]   Interatrial septal abnormalities and stroke - A meta-analysis of case-control studies [J].
Overell, JR ;
Bone, I ;
Lees, KR .
NEUROLOGY, 2000, 55 (08) :1172-1179
[24]   Brain gray matter changes in migraine patients with T2-visible lesions - A 3-T MRI study [J].
Rocca, Maria A. ;
Ceccarelli, Antonia ;
Falini, Andrea ;
Colombo, Bruno ;
Tortorella, Paola ;
Bernasconi, Luca ;
Comi, Giancarlo ;
Scotti, Giuseppe ;
Filippi, Massimo .
STROKE, 2006, 37 (07) :1765-1770
[25]   The puncture technique: A new method for transcatheter closure of patent foramen ovale [J].
Ruiz, CE ;
Alboliras, ET ;
Pophal, SG .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 53 (03) :369-372
[26]   Transvenous closure of secundum atrial septal defects - Preliminary results with a new self-expanding nitinol prosthesis in a swine model [J].
Sharafuddin, MJA ;
Gu, XP ;
Titus, JL ;
Urness, M ;
CerveraCeballos, JJ ;
Amplatz, K .
CIRCULATION, 1997, 95 (08) :2162-2168
[27]   Reliability of the migraine disability assessment score in a population-based sample of headache sufferers [J].
Stewart, WF ;
Lipton, RB ;
Kolodner, K ;
Liberman, J ;
Sawyer, J .
CEPHALALGIA, 1999, 19 (02) :107-114
[28]   RELATION BETWEEN PATENT FORAMEN OVALE AND UNEXPLAINED STROKE [J].
VANCAMP, G ;
SCHULZE, D ;
COSYNS, B ;
VANDENBOSSCHE, JL .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (07) :596-598
[29]   Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure [J].
Wertman, B ;
Azarbal, B ;
Riedl, M ;
Tobis, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1226-1227
[30]   Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke [J].
Windecker, S ;
Wahl, A ;
Nedeltchev, K ;
Arnold, M ;
Schwerzmann, M ;
Seiler, C ;
Mattle, HP ;
Meier, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (04) :750-758